Chronic Hepatitis C Linked to Higher Pancreatic Cancer Risk: JAMA
Written By : Medha Baranwal
Medically Reviewed By : Dr. Kamal Kant Kohli
Published On 2025-11-27 15:15 GMT | Update On 2025-11-27 15:16 GMT
Advertisement
USA: A large cohort study of over 6 million U.S. veterans, chronic hepatitis C virus infection significantly increases the risk of pancreatic ductal adenocarcinoma (PDAC). Even prior exposure to HCV—without chronic infection—was associated with a smaller but elevated risk. Because VA patients differ from the general population, external validation of these findings is necessary.
The study, published in
The retrospective cohort analysis drew on data from the Veterans Health Administration (VA), including individuals who had undergone HCV testing between 2001 and 2020. A total of 6,330,856 veterans were included, with a median age of 61.6 years. Among them, 246,218 had chronic HCV infection, and another 209,492 showed evidence of prior exposure without chronic disease. All participants were followed for at least 18 months after their initial VA visit.
The study led to the following findings:
- A total of 33,451 individuals developed PDAC during the study period.
- People with chronic HCV were diagnosed with PDAC at younger ages (median 65 years) compared with those without HCV (median 72.4 years).
- After adjustment for demographic and clinical factors, chronic HCV infection was associated with a 76% higher risk of PDAC (adjusted HR 1.76).
- Individuals with prior HCV exposure, but no chronic infection, still showed an 18% increased risk of developing PDAC.
- Risk varied by viral genotype, with genotype 3 showing the highest risk (aHR 2.02).
- Genotype 1 also carried a significantly elevated risk (aHR 1.75).
- Genotype 2 was associated with a lower, but still meaningful, increased risk (aHR 1.35).
The authors emphasized that chronic HCV appears to be a potentially modifiable risk factor for pancreatic cancer, underscoring the importance of timely diagnosis and antiviral treatment. They also highlighted the need for continued scientific exploration into the mechanisms by which persistent viral infection may contribute to pancreatic carcinogenesis.
However, the study has limitations. Its largely male VA population may limit broader applicability, and factors such as military exposures, socioeconomic differences, and healthcare access were not fully captured. Misclassification of metastatic disease and possible surveillance bias from more frequent imaging in chronic HCV patients also remain concerns. Even so, sensitivity analyses confirmed the consistency of the results.
The study provides strong evidence that chronic HCV infection increases the likelihood of developing PDAC, with certain genotypes posing even higher risks. The authors call for future research examining how direct-acting antiviral therapy may reduce this risk and unravel the biological pathways linking HCV to pancreatic cancer.
Reference:
Levinson RN, Bushman R, Tate JP, et al. Pancreatic Ductal Adenocarcinoma After Hepatitis C Infection. JAMA Netw Open. 2025;8(11):e2543701. doi:10.1001/jamanetworkopen.2025.43701
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.